HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF SEPSIS SYNDROME

被引：4
|
作者：
TOMPKINS, RG
机构：
来源：
CRITICAL CARE MEDICINE | 1994年 / 22卷 / 01期
关键词：
INTERLEUKIN-1; SEPSIS; CYTOKINES; PATIENT OUTCOME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
D O I：
10.1097/00003246-199401000-00002
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Comparative study of recombinant human interleukin-1 receptor antagonist for the treatment of patients with psoriatic and rheumatoid arthrites
    Ischenko, A.
    Kleymenova, I
    Raymuev, K.
    Soloviova, L.
    Antipova, T.
    Simbirtsev, A.
    8TH JOINT CONFERENCE OF THE INTERNATIONAL CYTOKINE SOCIETY AND THE INTERNATIONAL SOCIETY FOR INTERFERON AND CYTOKINE RESEARCH, 2010, : 13 - 16
  • [22] COST-EFFECTIVENESS OF TREATMENT WITH INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN PATIENTS WITH SEPSIS SYNDROME
    GORDON, GS
    FISHER, CJ
    SLOTMAN, GJ
    OPAL, SM
    PRIBBLE, JP
    STILES, DM
    CATALANO, MA
    CLINICAL RESEARCH, 1992, 40 (02): : A254 - A254
  • [23] Balance of interleukin-1β and interleukin-1 receptor antagonist in human periapical lesions
    Shimauchi, H
    Takayama, S
    Imai-Tanaka, T
    Okada, H
    JOURNAL OF ENDODONTICS, 1998, 24 (02) : 116 - 119
  • [24] The production and characterization of a modified recombinant interleukin-1 receptor antagonist
    Chang, DM
    Chou, WY
    IMMUNOLOGICAL INVESTIGATIONS, 1996, 25 (04) : 355 - 368
  • [25] Treatment of rheumatoid arthritis with a human recombinant Interleukin 1 receptor antagonist
    Rau, R
    Sander, O
    Musikic, P
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1998, 57 (05): : 312 - 319
  • [26] Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
    Joseph G. Cannon
    Jonathan B. Angel
    Leslie W. Abad
    Edouard Vannier
    Maria D. Mileno
    Laura Fagioli
    Sheldon M. Wolff
    Anthony L. Komaroff
    Journal of Clinical Immunology, 1997, 17 : 253 - 261
  • [27] Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
    Soennichsen, Astrid
    Saulite, Ieva
    Mangana, Johanna
    Kerl, Katrin
    Mehra, Tarun
    Desislava, Ignatova
    Chang, Yun-Tsan
    Petrausch, Ulf
    Schmid-Grendelmeier, Peter
    Hoetzenecker, Wolfram
    Cozzio, Antonio
    Guenova, Emmanuella
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (05) : 436 - 438
  • [28] Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist
    Chi, EY
    Kendrick, BS
    Carpenter, JF
    Randolph, TW
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (12) : 2735 - 2748
  • [29] BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    WELGUS, HG
    THOMPSON, RC
    EISENBERG, SP
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05): : 1694 - 1697
  • [30] Induction of interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 981 - 993
12345